Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection

NCT04728919 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2022-02-07

No results posted yet for this study

Summary

A Study of the relation of COVID-19 infection and its severity to upper and lower airway nitric oxide, upper airway viral load and lung function.

Conditions

Sponsors & Collaborators

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Lauri Lehtimäki, Professor · Tampere University Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2023-01-15
Completion
2024-01-15

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04728919 on ClinicalTrials.gov